Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04127604 · ClinicalTrials.gov registry record · NA
Post-Hospital Intervention for Veterans With Comorbid Bipolar and Substance Use Disorders
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 138
- Enrollment target
NCT04127604: Completed NA study, sponsored by VA Office of Research and Development.
NCT04127604 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 138 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04127604, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 138 participants
- Enrollment target
Study Summary
This trial aims to evaluate the effectiveness of a novel intervention for Veterans with co-occurring bipolar and substance use disorders following a psychiatric hospitalization. Half of the participants will receive a specialized psychosocial intervention program, while the other half will receive an enhanced safety monitoring program, both provided in addition to their routine care.
Primary Outcome
The Brief Adherence Rating Scale (BARS) assesses the percentage of missed medication doses over the past month. The total adherence score ranges from 0% to 100% and higher scores indicate greater adherence.
Interventions
- BEHAVIORAL Safety Assessment and Follow-up Evaluation (SAFE)
- BEHAVIORAL Integrated Treatment Adherence Program for Veterans (ITAP-VA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 138 participants |
| Start Date | 2020-11-02 |
| Est. Completion | 2025-09-30 |
| Phase | NA |
What the finished NCT04127604 record still lists
NCT04127604 is an interventional study that assigns participants to a tested intervention. The registered 138 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 2 interventions - of which Safety Assessment and Follow-up Evaluation (SAFE) is the first listed.
NCT04127604 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04127604 about?
NCT04127604 is a clinical study titled "Post-Hospital Intervention for Veterans With Comorbid Bipolar and Substance Use Disorders". This trial aims to evaluate the effectiveness of a novel intervention for Veterans with co-occurring bipolar and substance use disorders following a psychiatric hospitalization. Half of the participants will receive a specialized psychosocial intervention program, while the other half will receive a...
What is the current status of trial NCT04127604?
This trial is currently completed. It is a NA study. The enrollment target is 138 participants. The study started on 2020-11-02. Estimated completion is 2025-09-30.
What interventions are being tested in trial NCT04127604?
The interventions under investigation include: Safety Assessment and Follow-up Evaluation (SAFE) (BEHAVIORAL), Integrated Treatment Adherence Program for Veterans (ITAP-VA) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04127604?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04127604's enrollment target sits among peer trials
138 720th of 2000 higher than 1,279 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04402788 · 138 participants · Phase 2
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
- NCT04883255 · 138 participants · Early Phase 1
Cannabis Use, Cognition, and the Endocannabinoid System in HIV
- NCT05620784 · 138 participants · Phase 3
Intra-operative Loop Diuretics to Improve Same-day Discharge Rates After HoLEP
- NCT05832086 · 138 participants · Phase 2
Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI